RB
Rajendra Bhagat
About Rajendra Bhagat
Data last updated:
Rajendra Bhagat is a Managing Director at Klarzen Pharmaceuticals Private Limited (since 2019) and Director at Stanberg Pharmaceuticals Private Limited (since 2019). The companies operate in Chemicals and Trading. The largest current company by reported revenue is Klarzen Pharmaceuticals Private Limited at ₹4.5 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Managing Director | 18 Oct 2019 | 2019 | ₹4.5 Lakh (FY 2025) | Active | |
| Director | 26 Mar 2019 | 2019 | Under Process Of Striking Off |
Board colleagues of Rajendra Bhagat
| Name | DIN | Company | Designation |
|---|---|---|---|
| Sangita Devi | 09507094 | Klarzen Pharmaceuticals Private Limited | Director |
| Kanhaya Prasad | 08399935 | Stanberg Pharmaceuticals Private Limited | Managing Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Rajendra Bhagat
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rajendra Bhagat
Rajendra Bhagat currently holds 2 directorships: Klarzen Pharmaceuticals Private Limited (Managing Director, since 18 Oct 2019, revenue ₹4.5 Lakh (FY 2025)); Stanberg Pharmaceuticals Private Limited (Director, since 26 Mar 2019).
Rajendra Bhagat was first appointed on 26 Mar 2019 as Director at Stanberg Pharmaceuticals Private Limited.
The current boards of Rajendra Bhagat's companies include Sangita Devi (Klarzen Pharmaceuticals Private Limited), Kanhaya Prasad (Stanberg Pharmaceuticals Private Limited).